Global Anti-tumor Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Anti-tumor Drug Market Overview

• 1.1 Product Overview and Scope of Anti-tumor Drug
• 1.2 Classification of Anti-tumor Drug by Type
  • 1.2.1 Global Anti-tumor Drug Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Anti-tumor Drug Revenue Market Share by Type in 2019
  • 1.2.3 Cytotoxic Drugs
  • 1.2.4 Non-cytotoxic Drugs
• 1.3 Global Anti-tumor Drug Market by Application
  • 1.3.1 Overview: Global Anti-tumor Drug Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Alkylating Agents
  • 1.3.3 Anti-metabolism Drugs
  • 1.3.4 Platinum Antineoplastic Agents
  • 1.3.5 Anthracycline antitumor drugs
  • 1.3.6 Microtubule Stabilizer
  • 1.3.7 Endocrine Therapy Drugs
  • 1.3.8 Immunotherapy Drugs
  • 1.3.9 Gene Therapy Drugs
  • 1.3.10 Targeted Antineoplastic Drugs
• 1.4 Global Anti-tumor Drug Market by Regions
  • 1.4.1 Global Anti-tumor Drug Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Anti-tumor Drug (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Anti-tumor Drug Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Anti-tumor Drug Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-tumor Drug Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Anti-tumor Drug Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-tumor Drug Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Roche
  • 2.1.1 Roche Details
  • 2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Roche SWOT Analysis
  • 2.1.4 Roche Product and Services
  • 2.1.5 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Takeda
  • 2.2.1 Takeda Details
  • 2.2.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Takeda SWOT Analysis
  • 2.2.4 Takeda Product and Services
  • 2.2.5 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Bristol-Myers Squibb
  • 2.3.1 Bristol-Myers Squibb Details
  • 2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Bristol-Myers Squibb SWOT Analysis
  • 2.3.4 Bristol-Myers Squibb Product and Services
  • 2.3.5 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Novartis
  • 2.4.1 Novartis Details
  • 2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Novartis SWOT Analysis
  • 2.4.4 Novartis Product and Services
  • 2.4.5 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Pfizer
  • 2.5.1 Pfizer Details
  • 2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Pfizer SWOT Analysis
  • 2.5.4 Pfizer Product and Services
  • 2.5.5 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Celgene
  • 2.6.1 Celgene Details
  • 2.6.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Celgene SWOT Analysis
  • 2.6.4 Celgene Product and Services
  • 2.6.5 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 AstraZeneca
  • 2.7.1 AstraZeneca Details
  • 2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 AstraZeneca SWOT Analysis
  • 2.7.4 AstraZeneca Product and Services
  • 2.7.5 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Johnson & Johnson
  • 2.8.1 Johnson & Johnson Details
  • 2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Johnson & Johnson SWOT Analysis
  • 2.8.4 Johnson & Johnson Product and Services
  • 2.8.5 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Amgen
  • 2.9.1 Amgen Details
  • 2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Amgen SWOT Analysis
  • 2.9.4 Amgen Product and Services
  • 2.9.5 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Eli Lilly
  • 2.10.1 Eli Lilly Details
  • 2.10.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Eli Lilly SWOT Analysis
  • 2.10.4 Eli Lilly Product and Services
  • 2.10.5 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 Biogen Idec
  • 2.11.1 Biogen Idec Details
  • 2.11.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 Biogen Idec SWOT Analysis
  • 2.11.4 Biogen Idec Product and Services
  • 2.11.5 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 Otsuka
  • 2.12.1 Otsuka Details
  • 2.12.2 Otsuka Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 Otsuka SWOT Analysis
  • 2.12.4 Otsuka Product and Services
  • 2.12.5 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 Astellas
  • 2.13.1 Astellas Details
  • 2.13.2 Astellas Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 Astellas SWOT Analysis
  • 2.13.4 Astellas Product and Services
  • 2.13.5 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.14 Eisai
  • 2.14.1 Eisai Details
  • 2.14.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.14.3 Eisai SWOT Analysis
  • 2.14.4 Eisai Product and Services
  • 2.14.5 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.15 Bayer
  • 2.15.1 Bayer Details
  • 2.15.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.15.3 Bayer SWOT Analysis
  • 2.15.4 Bayer Product and Services
  • 2.15.5 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.16 Merck & Co
  • 2.16.1 Merck & Co Details
  • 2.16.2 Merck & Co Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.16.3 Merck & Co SWOT Analysis
  • 2.16.4 Merck & Co Product and Services
  • 2.16.5 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.17 Teva
  • 2.17.1 Teva Details
  • 2.17.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.17.3 Teva SWOT Analysis
  • 2.17.4 Teva Product and Services
  • 2.17.5 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)
• 2.18 Sanofi
  • 2.18.1 Sanofi Details
  • 2.18.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.18.3 Sanofi SWOT Analysis
  • 2.18.4 Sanofi Product and Services
  • 2.18.3 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Anti-tumor Drug Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Anti-tumor Drug Players Market Share
  • 3.2.2 Top 10 Anti-tumor Drug Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Anti-tumor Drug Revenue and Market Share by Regions
• 4.2 North America Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 4.3 Europe Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 4.5 South America Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Anti-tumor Drug Revenue and Growth Rate (2015-2020)

5 North America Anti-tumor Drug Revenue by Countries

• 5.1 North America Anti-tumor Drug Revenue by Countries (2015-2020)
• 5.2 USA Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 5.3 Canada Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Anti-tumor Drug Revenue and Growth Rate (2015-2020)

6 Europe Anti-tumor Drug Revenue by Countries

• 6.1 Europe Anti-tumor Drug Revenue by Countries (2015-2020)
• 6.2 Germany Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 6.3 UK Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 6.4 France Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 6.5 Russia Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 6.6 Italy Anti-tumor Drug Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Anti-tumor Drug Revenue by Countries

• 7.1 Asia-Pacific Anti-tumor Drug Revenue by Countries (2015-2020)
• 7.2 China Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 7.3 Japan Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 7.4 Korea Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 7.5 India Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Anti-tumor Drug Revenue and Growth Rate (2015-2020)

8 South America Anti-tumor Drug Revenue by Countries

• 8.1 South America Anti-tumor Drug Revenue by Countries (2015-2020)
• 8.2 Brazil Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Anti-tumor Drug Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Anti-tumor Drug by Countries

• 9.1 Middle East & Africa Anti-tumor Drug Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 9.3 UAE Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Anti-tumor Drug Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Anti-tumor Drug Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Anti-tumor Drug Revenue and Market Share by Type (2015-2020)
• 10.2 Global Anti-tumor Drug Market Forecast by Type (2019-2024)
• 10.3 Cytotoxic Drugs Revenue Growth Rate (2015-2025)
• 10.4 Non-cytotoxic Drugs Revenue Growth Rate (2015-2025)

11 Global Anti-tumor Drug Market Segment by Application

• 11.1 Global Anti-tumor Drug Revenue Market Share by Application (2015-2020)
• 11.2 Anti-tumor Drug Market Forecast by Application (2019-2024)
• 11.3 Alkylating Agents Revenue Growth (2015-2020)
• 11.4 Anti-metabolism Drugs Revenue Growth (2015-2020)
• 11.5 Platinum Antineoplastic Agents Revenue Growth (2015-2020)
• 11.6 Anthracycline antitumor drugs Revenue Growth (2015-2020)
• 11.7 Microtubule Stabilizer Revenue Growth (2015-2020)
• 11.8 Endocrine Therapy Drugs Revenue Growth (2015-2020)
• 11.9 Immunotherapy Drugs Revenue Growth (2015-2020)
• 11.10 Gene Therapy Drugs Revenue Growth (2015-2020)
• 11.11 Targeted Antineoplastic Drugs Revenue Growth (2015-2020)

12 Global Anti-tumor Drug Market Size Forecast (2021-2025)

• 12.1 Global Anti-tumor Drug Market Size Forecast (2021-2025)
• 12.2 Global Anti-tumor Drug Market Forecast by Regions (2021-2025)
• 12.3 North America Anti-tumor Drug Revenue Market Forecast (2021-2025)
• 12.4 Europe Anti-tumor Drug Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Anti-tumor Drug Revenue Market Forecast (2021-2025)
• 12.6 South America Anti-tumor Drug Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Anti-tumor Drug Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer